What SeaWith makes
SeaWith is a South Korean company with offices in Seoul and Daegu, a plant in Uiseong and an office in Seattle. It describes its work as a stem cell-based protein production platform. The headline product is a cultivated beef ingredient made from Hanwoo cells, Korean native cattle, positioned as a partial blend for ground meat, not a whole cut.
The company grows muscle and fat cells for the meat ingredient and skin cells for a cultivated leather. Spent culture medium goes into a cosmetics line sold under a separate brand. This model spreads fixed costs across products. For a food developer, the relevant output is the meat ingredient, within the field of cultivated beef and cultivated meat.
SeaWith also sells inputs to other cell-culture groups. Its cells and materials line supplies cell lines, a culture medium and scaffolds to research institutes and companies, plus toxicity and efficacy testing and custom cell isolation. The company says it has supplied and tested for more than 16 large companies and institutes, and that overseas supply is limited to research use.
Technology behind the products
The company lists four technologies. An automated cell isolation system processes Hanwoo tissue by the kilogram, which it says is far more efficient than manual work at 10 to 20 grams. Cells go into a bank of 6,000 vials, graded by AI tiering. The company claims isolation costs one sixtieth of the usual figure.
The culture medium, called ABC, is a food-grade, serum-free formulation made with extracts of spirulina and chlorella. It supports proliferation and differentiation in 2D and 3D formats without fetal bovine serum, and the company claims a 99% lower medium cost. Background on the algae is in the page on spirulina.
The scaffold, ACe-gel, is an edible bead made from alginate extracted from wakame seaweed without chemical refining. The company states it is 60% alginate and 90.7% dietary fibre, with no animal inputs, and cites a 2024 paper in Food Hydrocolloids showing cells attach and differentiate as on collagen. Edible scaffolds stay in the product and affect texture.
Bioreactor approach and production site
SeaWith grows adherent cells in a rocking, single-use bag reactor it calls CELLBATH. The company compares this with stainless steel stirred tanks, noting that sterilisation in place accounts for a share of fixed costs and that installation takes months. Its bags use food-grade materials that need no sterilisation. Equivalence is reported across 5, 50 and 500 litre scales.
The Uiseong production facility sits inside a special regulation zone for cell-cultivated food in Gyeongbuk province. It began operating in November 2025 and is run to GMP Class D standards. The cell culture room holds three 500 litre, two 50 litre and two 5 litre units, 1,500 litres in total, where batches for regulatory approval are run.
The site also houses an analysis laboratory that tests every batch, duplicate master and working cell banks in liquid nitrogen, a process development laboratory with benchtop reactors, and the automated isolation room. A separate site at Gwangmyeong is said to make 320 kilograms of scaffold per run. The company hosts visits for investors, partners and press on request.
The beef ingredient for food makers
The food page makes a commercial case: beef costs are rising along the supply chain and food makers cannot always pass them on, so a cell-grown ingredient could be priced independently of cattle markets. The company describes two weeks in the bioreactor, three weeks to finished product, and 4.0 kilograms of carbon dioxide equivalent per kilogram, labelled internal.
In use, the ingredient is meant to be blended into ground meat products at a partial share. The company says it is low in calories and saturated fat and high in fibre and protein, statements that need a published specification. A developer should ask for compositional data, texture results from burger or meatball trials, and sensory panel reports.
The news section reports a Hanwoo meatball shown at a technology week in Los Angeles in October 2025, and the cells and materials page mentions a September 2026 agreement with Handong on cultivated protein ingredients for pet food. Because cultivated products need approval before sale, any purchase plan should depend on authorisation in the market of sale.
How a buyer would evaluate the company
Buyers fall into two groups. Food companies exploring a cultivated beef component should ask about regulatory status in Korea and elsewhere, expected price, batch size, shelf life, frozen or chilled format and allergen declaration. They should also ask how the product is labelled and what share of a blend is realistic before flavour or texture differs from conventional ground beef.
Research groups buying cells or materials should request cell line characterisation, mycoplasma testing, passage history and population doublings achieved. The company reports population doubling levels of about eight for typical cells, twenty for its primary cells and seventy for its immortal-like muscle stem cells. Check how these were measured and whether the lines suit the intended food use.
Finally, weigh supplier maturity. The plant started operating recently, and the company is still running approval batches. Ask for audited financials, a supply continuity plan and the term of any exclusivity. Contact runs through the website form or the Seoul telephone line, and visits to the Uiseong facility can be requested.